| |
|
|
|
|
Gene Logic, Inc.(GLGC)
|
|
|
|
|
|
|
|
|
| 123Jump Rating: |
|
Underwriters: |
BancBoston
|
| |
|
|
Hambrecht & Quist
|
| Status: |
|
|
UBS Securities
|
| |
| Address: |
10150 Old Columbia Road
|
FiledDate: |
|
| |
|
|
|
| |
|
Filed Price Range ($): |
|
| |
|
|
|
| Telephone: |
(410) 309-3100 |
Filed Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Fax: |
|
Shares Offered (Millions): |
3,000,000 |
| |
|
|
|
| Websites: |
|
Shares Outstanding (Millions): |
13,382,377 |
| |
|
|
|
| Management: |
Alan G. Walton, Ph.D., D.Sc., Chairman of the Board
|
IPO Date: |
|
| |
Michael J. Brennan, M.D., Ph.D, Pres./CEO
|
|
|
| |
Mark D. Gessler, SVP/CFO
|
Final Offer Price ($): |
$0.00 |
| |
|
|
|
| Industry: |
|
Final Offer Size (Millions of Shares): |
0.00 |
| |
|
|
|
| Employees: |
57 |
Final Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Competitors: |
Human Genomics
|
S-1 Forms: |
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
- Avoid 
- Value Gap 
- Short-Term Growth
- Long-Term Growth 
- Long-Term Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Data |
| Year |
Revenues |
Costs |
Oper Income |
Taxes |
Net Income |
EPS |
| 1994
|
0.00 |
44.43 |
-90.4 |
0.00 |
-90.4 |
0.00 |
| 1995
|
0.00 |
485.68 |
-744.17 |
0.00 |
-745.07 |
0.00 |
| 1996
|
0.00 |
1741.46 |
-3086.43 |
0.00 |
-3358.64 |
-.31 |
| 1997
|
773.61 |
3338.14 |
-4944.84 |
100 |
-5599.27 |
-.46 |
* Period from Sept. 22 to Dec. 31, 1994
** Nine months ended Sept. 30, 1997
| |
|
|
|
|
|
|
| |
|
| |
|
|
